“…Hence, rapid screening for multiple b-blockers in a single analysis has been of growing demand in clinical toxicology and forensic science, 11 and antidoping control as well. 12 Betaxolol (BET), DL-[4-{2-cyclo-propylmethoxyethyl}-1-phenoxy-3-isopropylamino-2-propanol] (Scheme 1(a)), is a cardioselective b-adrenergic blocking agent characterized by a high bioavailability (90%) and a long half-life in man of about 16-22 h. 13 BET is an approved clinically used bblocker, 14 which produces vasodilatation and is effective for the treatment of arterial hypertension, intraocular hypertension, 15 coronary artery disease and chronic cardiovascular diseases. 16 Various analytical methods, such as gas chromatography-mass spectrometry (GC-MS) after derivatization, 17 liquid chromatography-mass spectrometry (LC-MS), 18 gas chromatographymass spectrometry in selected ion monitoring mode, 19 ultra-performance liquid chromatography-UV detection (UPLC-UV) 20 and UPLC-MS 21 have been applied for determination of different b-blockers.…”